Cargando…

Induction of Tolerance and Immunity by Dendritic Cells: Mechanisms and Clinical Applications

Dendritic cells (DCs) are key regulators of immune responses that operate at the interface between innate and adaptive immunity, and defects in DC functions contribute to the pathogenesis of a variety of disorders. For instance, cancer evolves in the context of limited DC activity, and some autoimmu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fucikova, Jitka, Palova-Jelinkova, Lenka, Bartunkova, Jirina, Spisek, Radek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830192/ https://www.ncbi.nlm.nih.gov/pubmed/31736936 http://dx.doi.org/10.3389/fimmu.2019.02393

Ejemplares similares

Cell Based Therapy for Type 1 Diabetes: Should We Take Hyperglycemia Into Account?
por: Grohová, Anna, et al.
Publicado: (2019)

Poly I: C-activated dendritic cells that were generated in CellGro for use in cancer immunotherapy trials
por: Fučíková, Jitka, et al.
Publicado: (2011)

Optimal Tolerogenic Dendritic Cells in Type 1 Diabetes (T1D) Therapy: What Can We Learn From Non-obese Diabetic (NOD) Mouse Models?
por: Funda, David P., et al.
Publicado: (2019)

NF-κB, p38 MAPK, ERK1/2, mTOR, STAT3 and increased glycolysis regulate stability of paricalcitol/dexamethasone-generated tolerogenic dendritic cells in the inflammatory environment
por: Dáňová, Klára, et al.
Publicado: (2015)

Antigen Loading (e.g., Glutamic Acid Decarboxylase 65) of Tolerogenic DCs (tolDCs) Reduces Their Capacity to Prevent Diabetes in the Non-Obese Diabetes (NOD)-Severe Combined Immunodeficiency Model of Adoptive Cotransfer of Diabetes As Well As in NOD Mice
por: Funda, David P., et al.
Publicado: (2018)

Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure induce strong immune responses and display therapeutic effects both in murine TC-1 and TRAMP-C2 tumors when combined with docetaxel chemotherapy
por: MIKYŠKOVÁ, ROMANA, et al.
Publicado: (2015)

Combinatorial Strategies for the Induction of Immunogenic Cell Death
por: Bezu, Lucillia, et al.
Publicado: (2015)

Corrigendum: “Combinatorial Strategies for the Induction of Immunogenic Cell Death”
por: Bezu, Lucillia, et al.
Publicado: (2015)

Myeloid - derived suppressor cells in Type 1 diabetes are an expanded population exhibiting diverse T-cell suppressor mechanisms
por: Grohová, Anna, et al.
Publicado: (2020)

Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer
por: Podrazil, Michal, et al.
Publicado: (2015)

Mechanisms of Tolerance Induction by Dendritic Cells In Vivo
por: Hasegawa, Hitoshi, et al.
Publicado: (2018)

Radiotherapy in Combination With Cytokine Treatment
por: Palata, Ondrej, et al.
Publicado: (2019)

Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinoma
por: Truxova, Iva, et al.
Publicado: (2023)

Calreticulin arms NK cells against leukemia
por: Fucikova, Jitka, et al.
Publicado: (2019)

Gliadin fragments promote migration of dendritic cells
por: Chladkova, Barbara, et al.
Publicado: (2011)

Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer
por: Fucikova, Jitka, et al.
Publicado: (2015)

Safety and efficacy of dendritic cell-based immunotherapy DCVAC/OvCa added to first-line chemotherapy (carboplatin plus paclitaxel) for epithelial ovarian cancer: a phase 2, open-label, multicenter, randomized trial
por: Rob, Lukas, et al.
Publicado: (2022)

Role of Dendritic Cells in the Induction of Lymphocyte Tolerance
por: Osorio, Fabiola, et al.
Publicado: (2015)

Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy
por: Adkins, Irena, et al.
Publicado: (2015)

Clinical Outcome of Coronavirus Disease 2019 in Patients with Primary Antibody Deficiencies
por: Milota, Tomas, et al.
Publicado: (2023)

Manipulation of Regulatory Dendritic Cells for Induction Transplantation Tolerance
por: Que, Weitao, et al.
Publicado: (2020)

CD4(+) T Cells of Prostate Cancer Patients Have Decreased Immune Responses to Antigens Derived From SARS-CoV-2 Spike Glycoprotein
por: Taborska, Pavla, et al.
Publicado: (2021)

Therapeutic Potential of Semi-Mature Dendritic Cells for Tolerance Induction
por: Lutz, Manfred B.
Publicado: (2012)

Pharmacologic Induction of Endotoxin Tolerance in Dendritic Cells by L-Kynurenine
por: Manni, Giorgia, et al.
Publicado: (2020)

Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients
por: Truxova, Iva, et al.
Publicado: (2018)

Detection of immunogenic cell death and its relevance for cancer therapy
por: Fucikova, Jitka, et al.
Publicado: (2020)

Immunological configuration of ovarian carcinoma: features and impact on disease outcome
por: Fucikova, Jitka, et al.
Publicado: (2021)

Tolerogenic dendritic cells generated in vitro using a novel protocol mimicking mucosal tolerance mechanisms represent a potential therapeutic cell platform for induction of immune tolerance
por: Dao Nyesiga, Gillian, et al.
Publicado: (2023)

Searching for the Transcriptomic Signature of Immune Tolerance Induction—Biomarkers of Safety and Functionality for Tolerogenic Dendritic Cells and Regulatory Macrophages
por: Navarro-Barriuso, Juan, et al.
Publicado: (2018)

RNA-seq of macrophages of amoeboid or mesenchymal migratory phenotype due to specific structure of environment
por: Čermák, Vladimír, et al.
Publicado: (2018)

Autologous dendritic cell immunotherapy (DCVAC/PCa) added to docetaxel chemotherapy in a Phase III trial (viable) in men with advanced (mCRPC) prostate cancer
por: Beer, Tomasz M, et al.
Publicado: (2015)

Data on microbial DNA-induced IL-1β production in monocytes of type 1 diabetes patients
por: Zentsova, Irena, et al.
Publicado: (2019)

Mast Cells and Dendritic Cells as Cellular Immune Checkpoints in Immunotherapy of Solid Tumors
por: Kalkusova, Katerina, et al.
Publicado: (2022)

Strategies for Deliberate Induction of Immune Tolerance in Liver Transplantation: From Preclinical Models to Clinical Application
por: Tanimine, Naoki, et al.
Publicado: (2020)

Editorial: Harnessing the Participation of Dendritic Cells in Immunity and Tolerance
por: Boscardin, Silvia Beatriz, et al.
Publicado: (2020)

The Dendritic Cell Dilemma in the Skin: Between Tolerance and Immunity
por: Scheib, Nils, et al.
Publicado: (2022)

Expression of tumor antigens on primary ovarian cancer cells compared to established ovarian cancer cell lines
por: Kloudová, Kamila, et al.
Publicado: (2016)

Transplantation Tolerance Induction: Cell Therapies and Their Mechanisms
por: Scalea, Joseph R., et al.
Publicado: (2016)

Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma
por: Partlová, Simona, et al.
Publicado: (2015)

Effectiveness and Durability of mRNA Vaccine-Induced SARS-CoV-2-Specific Humoral and Cellular Immunity in Severe Asthma Patients on Biological Therapy
por: Podrazil, Michal, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cap228at55qquqm9nig5spcap1